Literature DB >> 21205970

Terminology for preparations of botulinum neurotoxins: what a difference a name makes.

Alberto Albanese1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21205970     DOI: 10.1001/jama.2010.1937

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  25 in total

Review 1.  Use of botulinum toxin in individuals with neurogenic detrusor overactivity: state of the art review.

Authors:  Todd A Linsenmeyer
Journal:  J Spinal Cord Med       Date:  2013-09       Impact factor: 1.985

Review 2.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

3.  Clinical guidelines: No more mistaken identities for botulinum neurotoxins.

Authors:  Alberto Albanese
Journal:  Nat Rev Neurol       Date:  2016-06-17       Impact factor: 42.937

Review 4.  Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.

Authors:  A Ferrari; M Manca; V Tugnoli; L Alberto
Journal:  Funct Neurol       Date:  2018 Jan/Mar

Review 5.  The evaluation and management of refractory neurogenic overactive bladder.

Authors:  Raj Kurpad; Michael J Kennelly
Journal:  Curr Urol Rep       Date:  2014-10       Impact factor: 3.092

6.  Childhood dystonias.

Authors:  Samer D Tabbal
Journal:  Curr Treat Options Neurol       Date:  2015-03       Impact factor: 3.598

7.  OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity.

Authors:  Michael B Chancellor; Vaishali Patel; Wendy W Leng; Patrick J Shenot; Wayne Lam; Denise R Globe; Alex L Loeb; Christopher R Chapple
Journal:  Neurology       Date:  2013-07-26       Impact factor: 9.910

8.  Use of botulinum toxin type A in the management of patients with neurological disorders: a national survey.

Authors:  Nicola Smania; Carlo Colosimo; Anna Rita Bentivoglio; Giorgio Sandrini; Alessandro Picelli
Journal:  Funct Neurol       Date:  2013 Oct-Dec

9.  The Italian real-life post-stroke spasticity survey: unmet needs in the management of spasticity with botulinum toxin type A.

Authors:  A Picelli; A Baricich; C Cisari; Stefano Paolucci; Nicola Smania; Giorgio Sandrini
Journal:  Funct Neurol       Date:  2017 Apr/Jun

10.  Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey.

Authors:  Giorgio Sandrini; A Baricich; C Cisari; Stefano Paolucci; Nicola Smania; A Picelli
Journal:  Funct Neurol       Date:  2018 Jan/Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.